Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.

Abstract

The occurrence of sarcoidosis during anti-TNF-alpha therapy has occasionally been published. We report the case of a psoriasis patient who developed pulmonary sarcoidosis during a cycle of therapy with infliximab.

• Authors: S Izzi, F Francesconi, P Visca, A Altieri, C De Mutiis, G Trevisan, C Bonifati
• Journal: Dermatology online journal (Dermatol Online J) Vol. 16 Issue 5 Pg. 16 (May 15 2010) ISSN: 1087-2108 [Electronic] United States
• PMID: 20492833 (Publication Type: Case Reports, Letter)

Chemical References

• Antibodies, Monoclonal
• Antirheumatic Agents
• Tumor Necrosis Factor-alpha
• Infliximab

Topics

• Adult
• Antibodies, Monoclonal (administration & dosage, adverse effects)
• Antirheumatic Agents (administration & dosage, adverse effects)
• Arthritis, Psoriatic (drug therapy)
• Humans
• Infliximab
• Infusions, Intravenous
• Male
• Sarcoidosis, Pulmonary (chemically induced)
• Tumor Necrosis Factor-alpha (antagonists & inhibitors)